Description
This is a sources sought notice from the National Institute on Drug Abuse (NIDA) to identify capable vendors that can provide data extraction, management, analysis, and report of a propensity-score matched pharmacoepidemiological study of baclofen and spironolactone, prescribed for any indication, on HIV- and ASUD-related outcomes in a general patient population and a naturalistic setting, using the Veterans Aging Cohort Study (VACS). The objective of the proposed project is to examine GLP-1RAs and their potential health benefits for PLWH, in addition to alcohol and substance use disorders outcomes.
Key aspects of the project include:
• The capable vendor must have demonstrated experience in robust pharmacoepidemiology analyses with ASUD and HIV-related outcomes and identifying early efficacy signals with medications that can then be tested in prospective randomized controlled trials.
• The vendor must have experience in managing de-identified data.
• The vendor will be responsible for pulling, organizing, and cleaning the specific datasets.
• The period of performance is 12 months from the date of award with three 12-month option periods.